Glucose Empowerment Through Monitoring and Social Support in Pregnancy
This study is looking at whether using a continuous glucose monitor (CGM), which shows your blood sugar levels in real-time on a smartphone app, combined with a group chat for social support, can help pregnant individuals keep their blood sugar at a healthy level. High blood sugar during pregnancy can cause health problems for both you and your baby. Researchers believe that knowing your blood sugar levels instantly might help you make choices, like exercising or drinking water, to lower them. This study aims to enroll 70 pregnant women, aged 18-45, who are less than 20 weeks pregnant, have a BMI over 25, a personal history of gestational diabetes (GDM), or a first-degree family member with type 2 diabetes. You must also own a smartphone, be comfortable in English, and receive prenatal care at Tufts Medicine (Boston). The main goal is to see how this approach affects your confidence in managing your blood sugar.
- Study design
- This is an interventional study with a planned enrollment of 70 participants. It is not specified if it is randomized or blinded.
- What's involved
- You would use a continuous glucose monitor and participate in a mobile-based group chat. Your self-efficacy for glucose management will be measured at baseline, and on days 3, 7, 14, and 60 of the study.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your self-efficacy for glucose management will be measured up to Day 60 of the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Glucose Empowerment Through Monitoring and Social Support in Pregnancy
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Self-efficacy for glucose managementBaseline, Day 3 of CGM, Day 7 of CGM, Day 14 of CGM, Day 60 of study
Self-efficacy will be adapted from a validated survey of self-efficacy for type II diabetes management (DMSES UK)